ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00159250
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : February 23, 2010
Sponsor:
Collaborator:
Department of Health, United Kingdom
Information provided by:
Imperial College London

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2008
  Actual Study Completion Date : March 2009
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):